0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The multicellular signalling network of ovarian cancer metastases

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Transcoelomic spread is the major route of metastasis of ovarian high‐grade serous carcinoma (HGSC) with the omentum as the major metastatic site. Its unique tumour microenvironment with its large populations of adipocytes, mesothelial cells and immune cells establishes an intercellular signaling network that is instrumental for metastatic growth yet poorly understood.

          Methods

          Based on transcriptomic analysis of tumour cells, tumour‐associated immune and stroma cells we defined intercellular signaling pathways for 284 cytokines and growth factors and their cognate receptors after bioinformatic adjustment for contaminating cell types. The significance of individual components of this network was validated by analysing clinical correlations and potentially pro‐metastatic functions, including tumour cell migration, pro‐inflammatory signal transduction and TAM expansion.

          Results

          The data show an unexpected prominent role of host cells, and in particular of omental adipocytes, mesothelial cells and fibroblasts (CAF), in sustaining this signaling network. These cells, rather than tumour cells, are the major source of most cytokines and growth factors in the omental microenvironment ( n = 176 vs. n = 13). Many of these factors target tumour cells, are linked to metastasis and are associated with a short survival. Likewise, tumour stroma cells play a major role in extracellular‐matrix‐triggered signaling. We have verified the functional significance of our observations for three exemplary instances. We show that the omental microenvironment (i) stimulates tumour cell migration and adhesion via WNT4 which is highly expressed by CAF; (ii) induces pro‐tumourigenic TAM proliferation in conjunction with high CSF1 expression by omental stroma cells and (iii) triggers pro‐inflammatory signaling, at least in part via a HSP70–NF‐κB pathway.

          Conclusions

          The intercellular signaling network of omental metastases is majorly dependent on factors secreted by immune and stroma cells to provide an environment that supports ovarian HGSC progression. Clinically relevant pathways within this network represent novel options for therapeutic intervention.

          Abstract

          Besides macrophages, omental adipocytes, mesothelial cells and fibroblasts play an unexpectedly prominent role in the pro‐metastatic signaling network of ovarian carcinoma, encompassing clinically relevant pathways and potential therapeutic targets. The central role of stroma‐derived mediators is exemplified by (i) WNT4 stimulating tumour cell adhesion and migration, (ii) activation of pro‐inflammatory signaling by extracellular HSP70 and (iii) CSF1 inducing macrophage proliferation.

          Related collections

          Most cited references100

          • Record: found
          • Abstract: found
          • Article: not found

          STAR: ultrafast universal RNA-seq aligner.

          Accurate alignment of high-throughput RNA-seq data is a challenging and yet unsolved problem because of the non-contiguous transcript structure, relatively short read lengths and constantly increasing throughput of the sequencing technologies. Currently available RNA-seq aligners suffer from high mapping error rates, low mapping speed, read length limitation and mapping biases. To align our large (>80 billon reads) ENCODE Transcriptome RNA-seq dataset, we developed the Spliced Transcripts Alignment to a Reference (STAR) software based on a previously undescribed RNA-seq alignment algorithm that uses sequential maximum mappable seed search in uncompressed suffix arrays followed by seed clustering and stitching procedure. STAR outperforms other aligners by a factor of >50 in mapping speed, aligning to the human genome 550 million 2 × 76 bp paired-end reads per hour on a modest 12-core server, while at the same time improving alignment sensitivity and precision. In addition to unbiased de novo detection of canonical junctions, STAR can discover non-canonical splices and chimeric (fusion) transcripts, and is also capable of mapping full-length RNA sequences. Using Roche 454 sequencing of reverse transcription polymerase chain reaction amplicons, we experimentally validated 1960 novel intergenic splice junctions with an 80-90% success rate, corroborating the high precision of the STAR mapping strategy. STAR is implemented as a standalone C++ code. STAR is free open source software distributed under GPLv3 license and can be downloaded from http://code.google.com/p/rna-star/.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

            Efficient analysis of very large amounts of raw data for peptide identification and protein quantification is a principal challenge in mass spectrometry (MS)-based proteomics. Here we describe MaxQuant, an integrated suite of algorithms specifically developed for high-resolution, quantitative MS data. Using correlation analysis and graph theory, MaxQuant detects peaks, isotope clusters and stable amino acid isotope-labeled (SILAC) peptide pairs as three-dimensional objects in m/z, elution time and signal intensity space. By integrating multiple mass measurements and correcting for linear and nonlinear mass offsets, we achieve mass accuracy in the p.p.b. range, a sixfold increase over standard techniques. We increase the proportion of identified fragmentation spectra to 73% for SILAC peptide pairs via unambiguous assignment of isotope and missed-cleavage state and individual mass precision. MaxQuant automatically quantifies several hundred thousand peptides per SILAC-proteome experiment and allows statistically robust identification and quantification of >4,000 proteins in mammalian cell lysates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pseudo-temporal ordering of individual cells reveals dynamics and regulators of cell fate decisions

              Single-cell expression profiling by RNA-Seq promises to exploit cell-to-cell variation in gene expression to reveal regulatory circuitry governing cell differentiation and other biological processes. Here, we describe Monocle, a novel unsupervised algorithm for ordering cells by progress through differentiation that dramatically increases temporal resolution of expression measurements in a model of skeletal muscle differentiation. This reordering unmasks switch-like changes in expression of key regulatory factors, reveals sequentially organized waves of gene regulation, and exposes novel regulators of cell differentiation. A loss-of function screen revealed that many of these inhibitors act through regulatory elements also used by pro-myogenic factors to activate downstream genes. This study demonstrates that single-cell expression analysis by Monocle can uncover novel regulatory interactions governing differentiation. Cell differentiation is governed by a vast and complex gene regulatory program. During differentiation, each cell makes fate decisions independently by integrating a wide array of signals from other cells, executing a complex choreography of gene regulatory changes. Recently, several studies carried out at single-cell resolution have revealed high cell-to-cell variation in most genes during differentiation 1–5 , even among key developmental regulators. Although high variability complicates analysis of such experiments 6 , it might define biological progression between cellular states, revealing regulatory modules of genes that co-vary in expression across individual cells 7 . Prior studies have used approaches from computational geometry 8,9 and supervised machine learning 10 to order bulk cell populations from time-series microarray experiments by progress through a biological process. Applying this concept to order individual cells could expose fine-grained gene expression dynamics as they differentiate. We have developed Monocle, an algorithm that harnesses single cell variation to sort cells in “pseudo time” according to progress through differentiation. Applying Monocle to the classic model of myogenesis unveiled dynamics at unprecedented resolution and exposed novel regulatory factors. Skeletal myoblasts undergo a well-characterized sequence of morphological and transcriptional changes during differentiation 11 . Global expression and epigenetic profiles have reinforced the view that a small cohort of transcription factors (e.g. MYOD, MYOG, MRF4, and MYF5) orchestrates these changes 12 . However, efforts to expand this set of factors and map the broader myogenic regulatory network have been hampered by the temporal resolution of global expression measurements, with thousands of genes following a limited number of coarse kinetic trends 13 . Single-cell measurements of markers of myogenesis have made clear that cells do not progress through differentiation in synchrony. A population of cells captured at the same time may thus cover a range of distinct intermediate differentiation states. Drawing conclusions from a group of individuals based on the properties of their average is a hazardous practice because the average can mask important trends among the individuals, resulting in phenomena such as Simpson's paradox 14 . Experimental synchronization or stringent isolation of myogenic precursors is often challenging and dramatically alters differentiation kinetics. We hypothesized that capturing complete expression profiles of individual cells might avoid these problems and dramatically increase temporal resolution in global transcriptome dynamics. In essence, a single-cell RNA-Seq experiment might constitute a time-series, with each cell representing a distinct time point along a continuum. To test this hypothesis we investigated the single cell transcriptome dynamics during myogenesis. We expanded primary human myoblasts under high mitogen conditions (GM), and then induced differentiation by switching to low-mitogen media (DM). We then captured 50–100 cells at each of four time points following serum switch using the Fluidigm C1 microfluidic system. RNA from each cell was isolated and used to construct mRNA-Seq libraries, which were then sequenced to a depth of ~4 million reads per library, resulting in a complete gene expression profile for each cell (Fig 1a, S1). Averaging expression profiles of cells collected at the same time correlated well with the corresponding bulk RNA-Seq libraries, and moderately expressed genes were detectable (≥ 1 FPKM) in a majority of individual cells (Fig 1b, S2, S3). However, markers of mature myocytes were present at all time points following serum switch, and many other genes showed similar temporal heterogeneity (Fig 1c) We speculated that the high variability in cell-to-cell gene expression levels was due to unsynchronized differentiation, with myoblasts, intermediate myocytes, and mature myotubes residing in the same well concurrently. Indeed, large, multinucleated MYH2+ cells were abundant after 72 hours in DM, but these cells were present at lower frequency even at 24 hours (Fig 1c). We reasoned that informatically ordering the cells by their progress through differentiation, rather than by the time they were collected, would distinguish genes activated early in differentiation from those activated later. To this end, we developed a novel unsupervised algorithm, Monocle, which re-ordered the cells to maximize the transcriptional similarity between successive pairs (Fig 2a). The algorithm first represents the expression profile of each cell as a point in a high-dimensional Euclidean space, with one dimension for each gene. Second, it reduces the dimensionality of this space using Independent Component Analysis 15 . Third, Monocle constructs a minimum spanning tree (MST) on the cells, an approach now commonly used in other single-cell settings, such as flow or mass cytometry 16,17 . Fourth, the algorithm finds the longest path through the MST, corresponding to the longest sequence of transcriptionally similar cells. Finally, Monocle uses this sequence to produce a “trajectory” of an individual cell's progress through differentiation. Progress along a differentiation trajectory is measured in “pseudo-time”: the total transcriptional change a cell undergoes as it differentiates. This strategy is derived from a prior algorithm for temporally ordering microarray samples 8 , but extends it to allow for multiple cell fates stemming from a single progenitor cell type. As cells progress, they may diverge along two or more separate paths. After Monocle finds the longest sequence of similar cells, it examines cells not along this path to find alternative trajectories through the MST. These sub-trajectories are ordered and connected to the main trajectory, and each cell is annotated with both a trajectory and a pseudo-time value. Monocle thus orders cells by progress through differentiation and can reconstruct branched biological processes, which might arise when a precursor cell makes cell fate decisions that govern the generation of multiple subsequent lineages. Importantly, Monocle is unsupervised and needs no prior knowledge of specific genes that distinguish cell fates, and is thus suitable for studying a wide array of dynamic biological processes. Monocle decomposed myoblast differentiation into a two-phase trajectory and isolated a branch of non-differentiating cells (Fig 2b). The first phase of the trajectory was primarily composed of cells collected under high-mitogen conditions and which expressed markers of actively proliferating cells such as CDK1, while the second mainly consisted of cells collected at 24, 48, or 72 hours following serum switch. Cells in the second phase were positive for markers of muscle differentiation such as MYOG (Fig S4). A tightly grouped third population of cells branched from the trajectory near the transition between phases. These cells lacked myogenic markers but expressed PDGFRA and SPHK1, suggesting that they are contaminating interstitial mesenchymal cells and did not arise from the myoblasts. Such cells were recently shown to stimulate muscle differentiation 18 . Monocle's estimates of the frequency and proliferative status of these cells were consistent with estimates derived from immunofluorescent stains against ANPEP/CD13 and nuclear phosphorylated H3-Ser10 (Fig S4). Monocle thus enabled analysis of the myoblast differentiation trajectory without subtracting these cells by immunopurification, maintaining in vitro differentiation kinetics that resemble physiological cell crosstalk occurring in the in vivo niche. To find genes that were dynamically regulated as the cells progressed through differentiation, we modeled each gene's expression as a nonlinear function of pseudo-time. A total of 1,061 genes were dynamically regulated during differentiation (FDR = 0.8) to their relative order within the full data set. The algorithm retained the ability to detect dynamically regulated genes with high precision (>= 95%) over all designs and with increasing recall as more of the cells were included. (Fig S7) We next grouped genes with similar trends in expression, reasoning that such groups might share common biological functions and regulators. Clustering of genes according to direction and timing revealed six distinct trends (Fig 3). Genes downregulated early or upregulated late in pseudo-time were highly enriched for biological processes central to myogenesis, including cell-cycle exit and activation of muscle-specific structural proteins. However, the other clusters included many genes with broad roles in development, including mediators of cell-cell signaling, RNA export and translational control, and remodeling of cell morphology (Fig S8). A timeseries analysis of myoblast differentiation with bulk RNA-Seq identified up and down-regulated genes, but did not identify the transient clusters or distinguish the early from late regulation visible with pseudo-temporally ordered single cells (Fig S9). Furthermore, dynamic range of expression was compressed for most genes, confirming that failure to account for variability in progress through differentiation leads directly to the effects associated with Simpson's paradox. Pseudo-temporal cell ordering thus decomposes the coarse kinetic trends produced by conventional RNA-Seq into distinct, sequential waves of transcriptional reconfiguration. To identify factors driving myoblast differentiation, we performed a cis-regulatory analysis on genes in each pseudo-temporal cluster. Cis regulatory elements were first identified based on DNaseI hypersensitive sites in HSMM cells and HSMM-derived myotubes 20 , classified according to function according to histone marks 21 , and finally annotated with conserved transcription factor binding sites. While downregulated genes were enriched at near significant levels with binding sites for genes that play roles in proliferation (e.g. MAX, E2F, and NMYC), nearly all significantly enriched motifs fell near upregulated genes. These genes were highly enriched for regulatory elements containing binding motifs for 175 transcription factors, including numerous well-known regulators of myogenesis, such as MYOD, MYOG, PBX1, MEIS1, and the MEF2 family (Fig S10). Some, but not all, of these factors were revealed by a regulatory element analysis performed using bulk RNA-Seq data, underscoring the power of increased (pseudo) temporal resolution of single-cell analysis (Fig S11). A similar analysis of microRNA target sites identified miR-1, miR-206, miR-133, and numerous others as regulators of genes activated during myogenesis (Fig S12). Of these, only miR-1/206 target sites were significantly enriched among genes found to be transiently upregulated and then sharply downregulated. This may suggest that miR-1 and miR-206, which are expressed at an intermediate stage of myoblast differentiation, may act to strongly suppress a subset of genes activated earlier. Many of the transcription factors implicated by our cis regulatory analysis to govern differentiation had no previously appreciated role in muscle development. To test potential roles of these factors we performed an RNAi mediated loss of function screen for 11 candidates. Briefly, we virally expressed proliferating myoblasts with one of 44 distinct shRNAs targeting either one of these factors or a mock (non-targeting) control, followed by serum-induced differentiation for five days. We then measured the frequency and size of myosin heavy chain 2 (MYH2)-positive cells with a high-throughput immunofluorescence pipeline. Of the targets we tested, MZF1, ZIC1, XBP1, and USF1 showed significantly altered differentiation kinetics (Fig 4a,b, Fig S13) when depleted with two or more independent hairpins (FDR < 5%). Knockdown of XBP1, USF1, ZIC1, and MZF1 enhanced myotube formation, with larger myotubes containing a higher fraction of total nuclei than mock shRNA controls. Depletion of CUX1, ARID5B, POU2F1, and AHR also increased differentiation efficiency, albeit less significantly. Importantly, whole-well nuclei counts were similar between knockdowns and mock controls, indicating that enhanced differentiation was not simply a result of higher initial cell counts or increased proliferation. With the exception of ZIC1, forced overexpression did not substantially alter differentiation kinetics (data not shown). Notably, several of these factors have binding motifs that are highly enriched in promoters and enhancers that also have motifs for known muscle regulators (Fig 4c). For example, USF1 motifs are enriched in enhancers that also have MYOD motifs. Together, these results confirm that the transcription factors identified as possible regulators in fact play a role in myoblast differentiation, and demonstrate the power of Monocle for identifying key differentiation genes. Here, we report that individual myoblasts progress through differentiation in an unsynchronized manner, but that they can be reordered according to progress through differentiation. This pseudo-time ordering pinpoints key events in differentiation that are masked both by conventional bulk cell expression profiling, and by single-cell expression profiles ordered by time collected. The reordering resolves sequentially activated transcriptional sub-programs that are regulated by common factors. The temporal resolution offered by hundreds of ordered cells might enable future efforts to computationally infer novel gene-regulatory modules. For example, the enrichment of transiently upregulated genes for common microRNA target sites raises the question of whether those microRNAs are expressed later, curtailing what would have been higher levels of expression. Sequencing-based measurements of small RNAs and mRNAs from the same cell will provide answers to such systems-level questions. Moreover, single-cell analysis distinguishes cells of interest from contaminating cell types such as interstitial mesenchymal cells without experimental isolation that might disrupt cell-cell interactions important in the in vivo niche. We identified eight previously unappreciated transcription factors that dramatically influence the course of myoblast differentiation, thus proving the principle of pseudo-temporal analysis and expanding the catalog of regulators in this well-studied system. Several of the eight factors reported here may normally repress differentiation by competing with pro-myogenic factors for these regulatory elements. Alternatively, these inhibitors may co-occupy regulatory elements with pro-myogenic factors, preventing transactivation of their targets (Fig. 4d). Previous studies in other contexts provide mechanistic data supporting both of these models. USF1 inhibits MyoD autoactivation in Xenopus by competing with MyoD at its promoter through an alternative E-box 22 . Our results suggest that USF1 may repress a broad array of targets via E-box competition. CUX1 represses targets in several developmental contexts through binding site competition 23 . XBP1 was recently reported to inhibit myoblast differentiation in mice, potentially through the mechanisms proposed here 24 . Further experiments in these HSMM cells and myoblasts from other anatomic depots will be needed to confirm the mechanism of these factors. While the positive regulators of myogenesis have been well characterized, only a handful of inhibitors have been identified. The eight inhibitors reported here may shed light on how the balance of proliferation and differentiation is maintained during development and regeneration. Ordering the expression profiles of individual cells by biological progress is thus a powerful new tool for studying cell differentiation, and could in principle be used to map regulatory networks that govern a much wider array of biological processes. Supplementary Material 1
                Bookmark

                Author and article information

                Contributors
                silke.reinartz@uni-marburg.de
                rolf.mueller@uni-marburg.de
                Journal
                Clin Transl Med
                Clin Transl Med
                10.1002/(ISSN)2001-1326
                CTM2
                Clinical and Translational Medicine
                John Wiley and Sons Inc. (Hoboken )
                2001-1326
                08 November 2021
                November 2021
                : 11
                : 11 ( doiID: 10.1002/ctm2.v11.11 )
                : e633
                Affiliations
                [ 1 ] Department of Translational Oncology, Center for Tumor Biology and Immunology (ZTI) Philipps University Marburg Germany
                [ 2 ] Clinic for Gynecology, Gynecological Oncology and Gynecological Endocrinology University Hospital (UKGM) Marburg Germany
                [ 3 ] Genomics Core Facility, Center for Tumor Biology and Immunology (ZTI) Philipps University Marburg Germany
                [ 4 ] Institute of Molecular Oncology Philipps University Marburg Germany
                [ 5 ] The German Centre for Cardiovascular Research (DZHK), Partner Site Rhine‐Main Max Planck Institute for Heart and Lung Research Bad Nauheim Germany
                [ 6 ] Institute for Translational Proteomics, Philipps University Marburg Germany
                Author notes
                [*] [* ] Correspondence

                Silke Reinartz and Rolf Müller, Department of Translational Oncology, Center for Tumor Biology and Immunology (ZTI), Philipps University, Marburg, Germany.

                Email: silke.reinartz@ 123456uni-marburg.de ; rolf.mueller@ 123456uni-marburg.de

                Author information
                https://orcid.org/0000-0002-3015-5850
                https://orcid.org/0000-0003-3339-4248
                Article
                CTM2633
                10.1002/ctm2.633
                8574964
                34841720
                25a8dd23-5250-4941-8184-dabf5403b4d2
                © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 08 October 2021
                : 29 July 2021
                : 15 October 2021
                Page count
                Figures: 11, Tables: 1, Pages: 28, Words: 15639
                Funding
                Funded by: Deutsche Krebshilfe (German Cancer Aid)
                Award ID: 70113255
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                November 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.8 mode:remove_FC converted:08.11.2021

                Medicine
                adipocyte,carcinoma‐associated fibroblast,hsp70,mesothelial cell,metastasis,omentum,ovarian carcinoma,signaling network,tumour microenvironment,wnt4

                Comments

                Comment on this article